Completed
| Title | Topic | Completed | Funder |
| Healthcare-associated infections | Infections and infestations | 2013 | ECDPC |
| Ruxolitinib for the treatment of myelofibrosis | Cancer | 2013 | NICE STA |
| Advisory Group for National Specialised Services | Methods and resources | 2012 | NIHR HTA/AGNSS |
| Adjunctive colposcopy technologies | Cancer | 2012 | NICE DA |
| Bone markers | Musculoskeletal | 2012 | HTA TAR |
| Omalizumab for asthma in adults and children | Respiratory disorders | 2012 | NICE TAR (MTA) |
| Spinal fusion | Musculoskeletal | 2012 | Yale University |
| Tafamidis for TTR-FAP | Neurological | 2012 | NIHR HTA/AGNSS |
| Acupuncture for osteoarthritis of the knee | Complementary therapies | 2011 | NIHR |
| Dabigatran etexilate to prevent stroke | Cardiovascular | 2011 | NICE STA |
| EOS low dose 2D/3D X-ray imaging system | Musculoskeletal | 2011 | NICE DA |
| Fingolimod for MS | Musculoskeletal | 2011 | NICE STA |
| Frozen shoulder | Musculoskeletal | 2011 | HTA Programme |
| Maximizing the impact of systematic reviews | Knowledge transfer | 2011 | NIHR/CLAHRC LYB |
| Monitoring children's growth (2010) | Child health | 2011 | HTA TAR |
| Neuroimaging for epilepsy (2010) | Neurological | 2011 | HTA TAR |
| Register of ongoing systematic reviews | Methods and resources | 2011 | No external funding |
| Retigabine for epilepsy | Neurological | 2011 | NICE STA |
| Secondary prevention of relapse in depression | Mental health/behavioural | 2011 | HTA TAR |
| Smoking in pregnancy | Lifestyle and public health | 2011 | DHPRP/PHRC |
| Bevacizumab for breast cancer | Cancer | 2010 | NICE STA |
| Capecitabine for advanced gastric cancer | Cancer | 2010 | NICE STA |
| Follow up of childhood cancer survivors | Cancer | 2010 | Macmillan Cancer Support |
| Golimumab for psoriatic arthritis | Musculoskeletal | 2010 | NICE STA |
| Omalizumab for severe persistent allergic asthma in children | Respiratory disorders | 2010 | NICE STA |
| Photodynamic therapy (2009) | Cancer | 2010 | HTA TAR |
| Sun protection resources to prevent skin cancer | Cancer | 2010 | NICE |
| Trastuzumab for gastric cancer | Cancer | 2010 | NICE STA |
| Aldosterone antagonists for post-MI heart failure | Cardiovascular | 2009 | HTA TAR |
| Alitretinoin for hand eczema | Skin disorders | 2009 | NICE STA |
| Antiemetics for nausea and vomiting | Child health | 2009 | Candlelighters |
| Dissemination of research | Knowledge transfer | 2009 | MRC PHSRN |
| Dronedarone for atrial fibrillation | Cardiovascular | 2009 | NICE STA |
| FNP decision rules | Child health | 2009 | MRC |
| FNP serum markers | Child health | 2009 | MRC |
| Impact of price on smoking | Lifestyle and public health | 2009 | DHPRP/PHRC |
| Medical podcasts | Knowledge transfer | 2009 | No external funding |
| Paracetamol and NSAIDS post surgery | Perioperative care | 2009 | HTA TAR |
| Presumed consent for organ donation | Lifestyle and public health | 2009 | HTA TAR |
| Psoriatic arthritis (2009) | Musculoskeletal | 2009 | NICE TAR |
| Topotecan for cervical cancer | Cancer | 2009 | NICE STA |
| Adverse effects in economic models | Methods and resources | 2008 | HTA TAR |
| Adverse effects in systematic reviews | Methods and resources | 2008 | No external funding |
| Bereavement by suicide | Mental health/behavioural | 2008 | DHPRP |
| Colour vision testing | Endocrine/metabolic | 2008 | HTA Programme |
| Endovascular aneurysm repair | Cardiovascular | 2008 | NICE TAR |
| Enhanced external counter pulsation | Cardiovascular | 2008 | HTA TAR |
| Hitting the Headlines | Knowledge transfer | 2008 | NLH |
| Influenza drug treatments | Infections and infestations | 2008 | NICE TAR |
| Promoting breastfeeding | Obstetrics/gynaecology | 2008 | HTA Programme |
| Stapled haemorrhoidectomy | Digestive system | 2008 | NICE TAR |
| Sugammadex for reversal of muscle relaxation in GA | Perioperative care | 2008 | NICE TAR |
| Tobacco control | Lifestyle and public health | 2008 | DHPRP |
| Trastuzumab (Herceptin) in the media | Cancer | 2008 | No external funding |
| Catheter ablation in atrial fibrillation | Cardiovascular | 2007 | NICE TAR |
| Different treatment durations of clopidogrel | Cardiovascular | 2007 | NICE TAR |
| Faecal occult blood tests | Cancer | 2007 | NHSCSP |
| Monitoring children's growth | Child health | 2007 | HTA Programme |
| Peripheral artery disease imaging techniques | Cardiovascular | 2007 | HTA Programme |
| Preventing relapse in people with bipolar disorder | Mental health/behavioural | 2007 | NICE TAR |
| Rimonabant for obesity | Endocrine/metabolic | 2007 | NICE STA |
| Shiftwork | Lifestyle and public health | 2007 | DHPRP/PHRC |
| Sleep apnoea (2007) | Respiratory disorders | 2007 | NICE TAR |
| The evidence behind the Cancer Plan | Cancer | 2007 | Cancer Research UK |
| Volume and nature of primary care research | Methods and resources | 2007 | NPCRDC |
| Wider social determinants of health | Lifestyle and public health | 2007 | DHPRP/PHRC |
| Antibiotic prophylaxis for surgery | Infections and infestations | 2006 | NICE TAR |
| Barriers to patient participation in trials | Methods and resources | 2006 | NCRN |
| Increasing patient participation in trials | Methods and resources | 2006 | NCRN |
| Interventions to support carers | Neurological | 2006 | Parkinson's Disease Society |
| Management of overweight and obesity | Lifestyle and public health | 2006 | Centre for Public Health Excellence |
| Parenteral oestrogen for prostate cancer | Cancer | 2006 | NCRN |
| RCTs for policy interventions | Methods and resources | 2006 | NHS RMP |
| Screening to prevent pre-term birth | Obstetrics/gynaecology | 2006 | HTA/NSC |
| Second-line treatments for advanced ovarian cancer | Cancer | 2006 | NICE TAR |
| Wider public health | Lifestyle and public health | 2006 | DHPRP |
| Attention deficit hyperactivity disorder | Mental health/behavioural | 2005 | NICE TAR |
| Cancer waiting times | Cancer | 2005 | DoH |
| Chronic Fatigue Syndrome / ME (2005) | Musculoskeletal | 2005 | NCCPC |
| Diagnostic tests for haematuria | Urological | 2005 | HTA Programme |
| Docetaxel for prostate cancer | Cancer | 2005 | NICE TAR |
| EURONHEED | Knowledge transfer | 2005 | EC 5th Framework Program |
| Narrative synthesis: a methodology review | Methods and resources | 2005 | ESRCRMP |
| Prostate biopsy methods | Cancer | 2005 | NHSCSP |
| Psoriasis | Skin disorders | 2005 | NICE TAR |
| Psoriatic arthritis (2005) | Musculoskeletal | 2005 | NICE TAR |
| Psychosocial interventions | Cardiovascular | 2005 | One Health |
| Psychosocial interventions | Cancer | 2005 | One Health |
| Retinoblastoma | Child health | 2005 | NICE TAR |
| Self care support networks | Mental health/behavioural | 2005 | DoH |
| Antihypertensive drugs in black people | Cardiovascular | 2004 | Effective Health Care |
| Clopidogrel and aspirin in acute coronary syndromes | Cardiovascular | 2004 | NICE TAR |
| Clopidogrel and dipyridamole for vascular events | Cardiovascular | 2004 | NICE TAR |
| Colorectal cancer: guidance update | Cancer | 2004 | Effective Health Care |
| Communication skills in social work education | Knowledge transfer | 2004 | SCIE |
| COX-2 inhibitors in bladder cancer | Cancer | 2004 | NCRN |
| Decision-analytic modelling | Methods and resources | 2004 | HTA Programme |
| Delay in seeking medical help | Cardiovascular | 2004 | NHS Northern and Yorkshire |
| Diagnostic accuracy studies | Methods and resources | 2004 | HTA Programme |
| Head and neck cancer: guidance | Cancer | 2004 | Effective Health Care |
| Neuroimaging for epilepsy | Neurological | 2004 | HTA Programme |
| Renal failure: renal NSF | Urological | 2004 | DHPRP |
| Urinary tract infection in childhood | Child health | 2004 | Effective Health Care |
| Access to cardiac services | Cardiovascular | 2003 | DHPRP |
| Capecitabine for breast cancer | Cancer | 2003 | NICE TAR |
| Evaluating non-randomised intervention studies | Methods and resources | 2003 | HTA Programme |
| Haematological cancer: guidance | Cancer | 2003 | NICE |
| Inhalers for asthma and COPD | Respiratory disorders | 2003 | Effective Health Care |
| Multiple sclerosis (MS): national guidelines | Neurological | 2003 | NCCCC |
| Newer drugs for bipolar affective disorder | Mental health/behavioural | 2003 | NICE TAR |
| Newer drugs for epilepsy | Neurological | 2003 | NICE TAR |
| Nocturnal enuresis (2003) | Child health | 2003 | Effective Health Care |
| Outcomes measurement in psychiatry | Mental health/behavioural | 2003 | MRC |
| Photodynamic therapy (2003) | Cancer | 2003 | Barbara Stewart Cancer Trust |
| Sabotage and tampering | Service delivery | 2003 | NPSA |
| Spinal cord injuries services | Neurological | 2003 | NICE TAR |
| Taxanes for ovarian cancer: update | Cancer | 2003 | NICE TAR |
| Telephone consultations | Service delivery | 2003 | DHPRP |
| Access to the online evidence base | Knowledge transfer | 2002 | NHS Information Authority |
| Atypical antipsychotic drugs in schizophrenia | Mental health/behavioural | 2002 | NICE TAR |
| Breast cancer: guidance | Cancer | 2002 | NICE |
| Childhood obesity | Child health | 2002 | Effective Health Care |
| Chronic Fatigue Syndrome / ME (2002) | Musculoskeletal | 2002 | Effective Health Care |
| Glycoproteins (2002) | Cardiovascular | 2002 | NICE TAR |
| Hip dysplasia | Child health | 2002 | SFOSS |
| Homeopathy | Complementary therapies | 2002 | Effective Health Care |
| Management of depression in primary care | Mental health/behavioural | 2002 | Effective Health Care |
| Nicotine replacement therapy | Lifestyle and public health | 2002 | NICE TAR |
| Organ and tissue retention | Lifestyle and public health | 2002 | DHPRP |
| Patient safety | Service delivery | 2002 | DHPSRP |
| PLDH for ovarian cancer | Cancer | 2002 | NICE TAR |
| Quality of life following organ transplant | Lifestyle and public health | 2002 | DHPRP |
| Referral in primary care | Service delivery | 2002 | DHPRP |
| Sibutramine in obesity | Endocrine/metabolic | 2002 | NICE TAR |
| Topotecan and PLDH for ovarian cancer | Cancer | 2002 | NICE TAR |
| Trastuzumab for breast cancer | Cancer | 2002 | NICE TAR |
| Urological cancer: guidance | Cancer | 2002 | NICE |
| Vinorelbine for breast cancer | Cancer | 2002 | NICE TAR |
| Volunteering | Lifestyle and public health | 2002 | Home Office |
| Accessing the evidence | Knowledge transfer | 2001 | Effectiveness Matters |
| Acupuncture | Complementary therapies | 2001 | Effective Health Care |
| Caelyx for ovarian cancer | Cancer | 2001 | NICE TAR |
| Counselling in primary care | Mental health/behavioural | 2001 | Effectiveness Matters |
| Debriding agents for chronic wounds | Wounds and accidents | 2001 | HTA TAR |
| Double reading mammograms | Cancer | 2001 | DoH |
| Heart failure | Cardiovascular | 2001 | DHPRP |
| Indirect comparisons of competing interventions | Methods and resources | 2001 | HTA Programme |
| Laxatives in adults | Digestive system | 2001 | Effective Health Care |
| Maternity care leaflets | Obstetrics/gynaecology | 2001 | DoH |
| Mental health services | Mental health/behavioural | 2001 | DoH |
| Promoting individual behaviour change | Lifestyle and public health | 2001 | HTA Programme |
| Taxanes for breast cancer: update | Cancer | 2001 | NICE TAR |
| Topotecan for ovarian cancer | Cancer | 2001 | NICE TAR |
| Cognitive impairment | Mental health/behavioural | 2000 | HTA Programme |
| Communicating with people who have cancer | Cancer | 2000 | Effective Health Care |
| False negative results | Methods and resources | 2000 | HTA Programme |
| Glycoproteins (2000) | Cardiovascular | 2000 | NICE TAR |
| Low back pain | Musculoskeletal | 2000 | Effective Health Care |
| Orlistat in obesity | Endocrine/metabolic | 2000 | NICE TAR |
| Promoting breastfeeding initiation | Obstetrics/gynaecology | 2000 | Effective Health Care |
| Psychosocial interventions for schizophrenia | Mental health/behavioural | 2000 | Effective Health Care |
| Publication bias | Methods and resources | 2000 | HTA Programme |
| Screening uptake | Service delivery | 2000 | HTA Programme |
| Taxanes for ovarian and breast cancer | Cancer | 2000 | NICE TAR |
| Upper gastro-intestinal cancer: guidance | Cancer | 2000 | Effective Health Care |
| Water fluoridation | Oral health | 2000 | DHPRP |
| Wound care management | Wounds and accidents | 2000 | HTA Programme |
| Antimicrobial prophylaxis in hip surgery | Musculoskeletal | 1999 | DoH |
| Community treatment for offenders | Mental health/behavioural | 1999 | HSPSCB |
| Debridement of chronic wounds | Wounds and accidents | 1999 | HTA Programme |
| Dental restorations - fillings | Oral health | 1999 | Scottish Office |
| Diabetes: renal disease and self-management | Endocrine/metabolic | 1999 | Effective Health Care |
| Diabetes: retinopathy; foot ulcers | Endocrine/metabolic | 1999 | Effective Health Care |
| Dressings and topical agents for wounds | Wounds and accidents | 1999 | HTA Programme |
| Drug treatments for schizophrenia | Mental health/behavioural | 1999 | Effective Health Care |
| Epidemiology of mentally disordered offenders | Mental health/behavioural | 1999 | HSPSCB |
| Essential hypertension | Cardiovascular | 1999 | Effectiveness Matters |
| Getting evidence into practice | Knowledge transfer | 1999 | Effective Health Care |
| Gynaecological cancer: guidance | Cancer | 1999 | Effective Health Care |
| Head lice and scabies | Child health | 1999 | Effectiveness Matters |
| Health and care of mentally disordered offenders | Mental health/behavioural | 1999 | HSPSCB |
| Preventing the uptake of smoking | Lifestyle and public health | 1999 | Effective Health Care |
| Prophylactic removal of wisdom teeth | Oral health | 1999 | NICE TAR |
| School based health promotion | Lifestyle and public health | 1999 | HTA Programme |
| Sleep apnoea (1999) | Respiratory disorders | 1999 | DoH |
| Women and secure psychiatric services | Mental health/behavioural | 1999 | HSPSCB |
| Antimicrobial prophylaxis in colorectal surgery | Infections and infestations | 1998 | Effective Health Care |
| Bone marrow for malignancy | Cancer | 1998 | HTA Programme |
| Cardiac rehabilitation | Cardiovascular | 1998 | Effective Health Care |
| Cholesterol and heart disease | Cardiovascular | 1998 | Effective Health Care |
| Deliberate self-harm | Mental health/behavioural | 1998 | DoH |
| Lung cancer: guidance | Cancer | 1998 | Effective Health Care |
| Ovarian cancer screening | Cancer | 1998 | HTA Programme |
| Screening for speech and language delay | Lifestyle and public health | 1998 | Effective Health Care |
| Smoking cessation | Lifestyle and public health | 1998 | Effectiveness Matters |
| Systematic reviews methods in HTA | Methods and resources | 1998 | HTA Programme |
| Alcohol misuse: health promotion | Lifestyle and public health | 1997 | HEA |
| Chronic stable angina | Cardiovascular | 1997 | Effective Health Care |
| Colorectal cancer: guidance | Cancer | 1997 | Effective Health Care |
| Compression treatment for leg ulcers | Wounds and accidents | 1997 | Effective Health Care |
| Home parenteral nutrition | Cancer | 1997 | HTA Programme |
| Hospital volume and outcomes | Service delivery | 1997 | Effective Health Care |
| Laxatives for the elderly | Digestive system | 1997 | HTA Programme |
| Mental health promotion in high risk groups | Mental health/behavioural | 1997 | Effective Health Care |
| Nocturnal enuresis (1997) | Child health | 1997 | ERIC |
| Preschool vision screening | Child health | 1997 | Effective Health Care |
| Preventing unintended teenage pregnancies | Lifestyle and public health | 1997 | Effective Health Care |
| Screening for prostate cancer | Cancer | 1997 | Effectiveness Matters |
| Substance misuse: health promotion | Lifestyle and public health | 1997 | HEA |
| Bone density and osteoporosis | Musculoskeletal | 1996 | INAHTA |
| Cataracts | Eye disorders | 1996 | Effective Health Care |
| Coronary heart disease and stroke: health promotion | Cardiovascular | 1996 | HEA |
| Ethnicity and health - guidance for purchasers | Service delivery | 1996 | NHS Executive West Midlands |
| Influenza vaccination | Infections and infestations | 1996 | Effectiveness Matters |
| Management of breast cancer | Cancer | 1996 | Effective Health Care |
| Obesity prevention and treatment | Endocrine/metabolic | 1996 | Effective Health Care |
| Preventing falls in older people | Wounds and accidents | 1996 | Effective Health Care |
| Preventing unintentional injuries in children | Child health | 1996 | Effective Health Care |
| Total hip replacement | Musculoskeletal | 1996 | Effective Health Care |
| Wisdom teeth | Oral health | 1996 | Faculty of Dental Surgery, RCSE |
| Aspirin and myocardial infarction | Cardiovascular | 1995 | Effectiveness Matters |
| Benign prostatic hyperplasia | Urological | 1995 | Effective Health Care |
| Care of critically ill children | Child health | 1995 | NHS Executive |
| H pylori and peptic ulcer | Digestive system | 1995 | Effective Health Care |
| Management of menorrhagia | Obstetrics/gynaecology | 1995 | Effective Health Care |
| Pressure sores | Skin disorders | 1995 | Effective Health Care |
| Reducing health variations | Lifestyle and public health | 1995 | NHS Executive |
| Volume and quality of health care | Service delivery | 1995 | DoH |
| Implementing clinical practice guidelines | Knowledge transfer | 1994 | Effective Health Care |
| Brief interventions and alcohol use | Lifestyle and public health | 1993 | DoH |
| Cholesterol: screening and treatment | Cardiovascular | 1993 | Effective Health Care |
| Treatment of depression in primary care | Mental health/behavioural | 1993 | Effective Health Care |
| Glue ear in children | Child health | 1992 | Effective Health Care |
| Management of subfertility | Obstetrics/gynaecology | 1992 | Effective Health Care |
| Screening for osteoporosis | Musculoskeletal | 1992 | Effective Health Care |